Bruce E Corigliano, MD | |
1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 | |
(626) 851-1011 | |
Not Available |
Full Name | Bruce E Corigliano |
---|---|
Gender | Male |
Speciality | Internal Medicine - Critical Care Medicine |
Location | 1011 Baldwin Park Blvd, Baldwin Park, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285705251 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | G37781 (California) | Primary |
Entity Name | Southern California Permanente Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Scars - in particular keloid scars that result from overgrowth of skin tissue after injuries or surgeries - are unsightly and can even lead to disfigurement and psychological problems of affected patients. Individuals with darker pigmentation - in particular people with African, Hispanic or South-Asian genetic background - are more likely to develop this skin tissue disorder.
Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.
Female teenagers living in neighbourhoods with wide salary gaps and a low-income household show changes to their brain maturation that could indicate a higher risk of developing mental illness in adulthood, suggests a recently published study by Canadian researchers.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Bruce E Corigliano, MD 1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 Ph: (626) 851-1011 | Bruce E Corigliano, MD 1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 Ph: (626) 851-1011 |
News Archive
Scars - in particular keloid scars that result from overgrowth of skin tissue after injuries or surgeries - are unsightly and can even lead to disfigurement and psychological problems of affected patients. Individuals with darker pigmentation - in particular people with African, Hispanic or South-Asian genetic background - are more likely to develop this skin tissue disorder.
Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.
Female teenagers living in neighbourhoods with wide salary gaps and a low-income household show changes to their brain maturation that could indicate a higher risk of developing mental illness in adulthood, suggests a recently published study by Canadian researchers.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).
› Verified 8 days ago
Arjang Kasravi, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 800-780-1277 | |
Dr. Jennifer Jang, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-813-4725 Fax: 626-813-4684 | |
Rody A. Yoshinaka, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Carolyn Anne Hardy, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Dennis Matejka, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Dr. Jayon Kim, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Previn J De Silva, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 |